Hoth Therapeutics has shared phase 2 results on its treatment of EGFR inhibitor-induced skin toxicities, ticking off another ...

The renewed interest in Citrus Burn is not about stronger stimulants. It is about a citrus-derived metabolic mechanism that ...

Researchers have identified a promising new weapon against triple-negative breast cancer, one of the most aggressive forms of ...